Literature DB >> 10947989

Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3.

G A McQuibban1, J H Gong, E M Tam, C A McCulloch, I Clark-Lewis, C M Overall.   

Abstract

Tissue degradation by the matrix metalloproteinase gelatinase A is pivotal to inflammation and metastases. Recognizing the catalytic importance of substrate-binding exosites outside the catalytic domain, we screened for extracellular substrates using the gelatinase A hemopexin domain as bait in the yeast two-hybrid system. Monocyte chemoattractant protein-3 (MCP-3) was identified as a physiological substrate of gelatinase A. Cleaved MCP-3 binds to CC-chemokine receptors-1, -2, and -3, but no longer induces calcium fluxes or promotes chemotaxis, and instead acts as a general chemokine antagonist that dampens inflammation. This suggests that matrix metalloproteinases are both effectors and regulators of the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10947989     DOI: 10.1126/science.289.5482.1202

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  218 in total

1.  Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis.

Authors:  L Guedez; A J McMarlin; D W Kingma; T A Bennett; M Stetler-Stevenson; W G Stetler-Stevenson
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

Review 2.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

3.  An extracellular matrix-associated zinc metalloprotease is required for dilauroyl phosphatidylethanolamine chemotactic excitation in Myxococcus xanthus.

Authors:  Daniel B Kearns; Pamela J Bonner; Daniel R Smith; Lawrence J Shimkets
Journal:  J Bacteriol       Date:  2002-03       Impact factor: 3.490

4.  Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets.

Authors:  Anna Radomski; Paul Jurasz; Esmond J Sanders; Christopher M Overall; Heather F Bigg; Dylan R Edwards; Marek W Radomski
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

Review 5.  Clinical implications of matrix metalloproteinases.

Authors:  Malay Mandal; Amritlal Mandal; Sudip Das; Tapati Chakraborti; Chakraborti Sajal
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

Review 6.  Metalloproteinases, inflammation, and rheumatoid arthritis.

Authors:  F F Mohammed; D S Smookler; R Khokha
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

7.  Identification of CED-3 substrates by a yeast-based screening method.

Authors:  Sung Yun Kim; Marcela Valencia; Eui Seung Lee; Daeho Park; Myungsok Oh; Ding Xue; Woo Jin Park
Journal:  Mol Biotechnol       Date:  2004-05       Impact factor: 2.695

8.  Fell-Muir Lecture: Metalloproteinases: from demolition squad to master regulators.

Authors:  Gillian Murphy
Journal:  Int J Exp Pathol       Date:  2010-08       Impact factor: 1.925

9.  Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis.

Authors:  Pallavi Garg; Matam Vijay-Kumar; Lixin Wang; Andrew T Gewirtz; Didier Merlin; Shanthi V Sitaraman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-02       Impact factor: 4.052

10.  Systems-level analysis of proteolytic events in increased vascular permeability and complement activation in skin inflammation.

Authors:  Ulrich auf dem Keller; Anna Prudova; Ulrich Eckhard; Barbara Fingleton; Christopher M Overall
Journal:  Sci Signal       Date:  2013-01-15       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.